NIVAS News Hub

Do you have news you would like to share on the NIVAS News Hub?

If you have an RSS feed you wish to share with up please contact us here.

Showing 49-60 of 2219 results.

IVTEAM

Telemedicine-supported home-injection model for patients – Full Text

"In this quality improvement study of a telemedicine-supported home injection model for women with breast cancer, strong feasibility was demonstrated by high injection completion rates and acceptability by participants. The findings suggest that insurance approval and the copayments associated with at-home, but not in-clinic, administration were an impediment to participation and need to be addressed before scaling" Malling et al (2026).

IVTEAM

Reducing intravenous smart pump alert override rates

"This study expands on the IVSP alert data published to date and highlights 3 key measures of alert override rates, including alert salience. Understanding the frequency and types of IVSP alerts and alert responses is critical for reducing unnecessary IVSP alerts and reducing alert fatigue" Armistead et al (2026).

IVTEAM

Practical guide to intrathecal drug delivery

"This practical guide synthesizes current evidence, consensus recommendations, and collective international clinical experience to provide a structured approach to short-term and long-term management of implantable IDD systems" Sivanesan et al (2026).

IVTEAM

Vascular access management plan for neonates

"Proper use of the Vascular Access Management Plan (VAMP) ensures choosing the right vascular access device from the start of therapy. The VAMP method offers a structured and patient-centered approach to vascular access in neonates" van Rens et al (2026).

IVTEAM

Review of the aseptic non-touch technique in intravenous therapy

"Successful integration of ANTT in China requires the development of localized, evidence-based protocols, multimodal training resources (including virtual simulation), and context-specific implementation strategies. Future research should prioritize rigorous, multi-center clinical trials to establish the effectiveness and cost-effectiveness of ANTT across diverse clinical settings in China" Jiajia et al (2026).

NIVAS Partners

The NIVAS Board

UK Vessel Health & Preservation Video